These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30030358)

  • 1. Proceedings of the 2017 Viral Clearance Symposium, Session 3: Resin Lifetime.
    Blümel J; Ma J
    PDA J Pharm Sci Technol; 2018; 72(5):488-497. PubMed ID: 30030358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Evaluation of Cycled Resin in Viral Clearance Studies-A Multiple Company Collaboration.
    Mattila J; Curtis S; Webb-Vargas Y; Wilson E; Galperina O; Roush D; Tobler S; Stanley B; Clark M; Weaver J; Pike J; Yu D; Li X; Flicker A; Kindermann J; Schuelke N; Whitcombe R; Bennett L
    PDA J Pharm Sci Technol; 2019; 73(5):470-486. PubMed ID: 31101706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings of the 2017 Viral Clearance Symposium, Session 2.2: DSP Unit Operations-Purification Unit Operations.
    Roush D; Kreil TR
    PDA J Pharm Sci Technol; 2018; 72(5):479-487. PubMed ID: 30030354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings of the 2017 Viral Clearance Symposium Session 5: Facility Risk Mitigation.
    Ma J; Kreil TR
    PDA J Pharm Sci Technol; 2018; 72(5):511-515. PubMed ID: 30030359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings of the 2017 Viral Clearance Symposium: Conclusion.
    Hepbildikler S; Johnson S; Bluemel J
    PDA J Pharm Sci Technol; 2018; 72(5):525-530. PubMed ID: 30030353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings of the 2017 Viral Clearance Symposium, Session 6: Ensuring Viral Safety in Continuous Processing.
    Johnson SA; Roush D
    PDA J Pharm Sci Technol; 2018; 72(5):516-524. PubMed ID: 30030352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings of the 2017 Viral Clearance Symposium, Session 2.1: DSP Unit Operations-Virus Filtration/Inactivation.
    Kreil TR; Roush D
    PDA J Pharm Sci Technol; 2018; 72(5):470-478. PubMed ID: 30030356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings of the 2017 Viral Clearance Symposium.
    Hepbildikler S; Nothelfer F
    PDA J Pharm Sci Technol; 2018; 72(5):453-454. PubMed ID: 30030350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiproduct Resin Reuse for Clinical and Commercial Manufacturing-Methodology and Acceptance Criteria.
    Sharnez R; Doares S; Manning S; Mehta K; Mahajan E; To A; Daniels W; Glynn J; Dhamane S; Wen X; Wang Y; Gour P; Guenther C; Foley D; Hayes R; Mott A; Prabhu S; Tavalsky D; Hendershot M; Haas D; Hesslein A; Schuelke N; Tjandra H
    PDA J Pharm Sci Technol; 2018; 72(6):584-598. PubMed ID: 30030349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings of the 2017 Viral Clearance Symposium, Session 4: Submission Strategies.
    Schwantes A; Specht R; Chen Q
    PDA J Pharm Sci Technol; 2018; 72(5):498-510. PubMed ID: 30030357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings of the 2019 Viral Clearance Symposium, Session 1: Viral Clearance Strategies and Case Studies.
    Reitz S; Schwantes A
    PDA J Pharm Sci Technol; 2022; 76(4):297-305. PubMed ID: 34911829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings of the 2017 Viral Clearance Symposium, Session 1.2: Upstream Mitigation, Part 2-Virus Barrier Filter and HTST.
    Chen D; Bolton G
    PDA J Pharm Sci Technol; 2018; 72(5):462-469. PubMed ID: 30030355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of various processing steps for viral clearance of therapeutic proteins: database analyses of commonly used steps.
    Cipriano D; Burnham M; Hughes JV
    Methods Mol Biol; 2012; 899():277-92. PubMed ID: 22735960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral clearance studies on new and used chromatography resins: critical review of a large dataset.
    Kelley BD; Jakubik J; Vicik S
    Biologicals; 2008 Mar; 36(2):88-98. PubMed ID: 17997110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings of the 2019 Viral Clearance Symposium, Session 4: Viral Clearance Strategy and Process Understanding.
    Roush D; Blümel J
    PDA J Pharm Sci Technol; 2022; 76(4):323-338. PubMed ID: 34911824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings of the 2019 Viral Clearance Symposium, Session 8. Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments and Actions.
    Bolton G
    PDA J Pharm Sci Technol; 2022; 76(4):362-367. PubMed ID: 34911826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings of the 2009 Viral Clearance Symposium.
    Miesegaes G; Bailey M; Willkommen H; Chen Q; Roush D; Blümel J; Brorson K
    Dev Biol (Basel); 2010; 133():3-101. PubMed ID: 21516942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real time quantitative PCR as a method to evaluate xenotropic murine leukemia virus removal during pharmaceutical protein purification.
    Shi L; Chen Q; Norling LA; Lau AS; Krejci S; Xu Y
    Biotechnol Bioeng; 2004 Sep; 87(7):884-96. PubMed ID: 15334415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings of the 2019 Viral Clearance Symposium, Session 6: Virus-Retentive Filtration.
    O'Donnell S; Bolton G
    PDA J Pharm Sci Technol; 2022; 76(4):349-357. PubMed ID: 34911825
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.